Author Interviews, Cancer Research, HPV / 13.06.2025

MedicalResearch.com Interview with: [caption id="attachment_69031" align="alignleft" width="150"]Pragati Advani MD, MPH, DrPHAssistant Professor of Oncology, Department of Thoracic Surgery And on faculty with the Department of Cancer Prevention and Population Sciences Roswell Park Comprehensive Cancer Center Buffalo, NY Dr. Advani[/caption] Pragati Advani MD, MPH, DrPH Assistant Professor of Oncology, Department of Thoracic Surgery And on faculty with the Department of Cancer Prevention and Population Sciences Roswell Park Comprehensive Cancer Center Buffalo, NY MedicalResearch.com: What is the background for this study? Response: In oncology, a study of second primary malignancy (SPM) is an emerging field that is predominantly driven by our success in identifying and treating the first primary cancers (FPCs). HPV is responsible for nearly a third of all infectious agent-related FPCs (including cancer of the oropharynx, anus, vulva, vagina, cervix and penis). Advances in diagnostic and treatment methods have resulted in improved survivorship among these patients. However, they remain at risk for developing a SPM. No studies thus far had examined the risk of SPMs after HPV-associated FPCs, stratified by cancer site and gender.
Author Interviews, Pain Research, Pharmacology / 09.06.2025

[caption id="attachment_68966" align="alignleft" width="200"]Prof. Alexander Binshtok PhDCecile and Seymour Alpert Professor in Pain Research Hebrew University’s Faculty of Medicine and Center for Brain Sciences (ELSC)  Dr. Binshtok[/caption] MedicalResearch.com Interview with: Prof. Alexander Binshtok PhD Cecile and Seymour Alpert Professor in Pain Research Hebrew University’s Faculty of Medicine and Center for Brain Sciences (ELSC) MedicalResearch.com: What is the background for this study? Response: Paracetamol (also known as acetaminophen) is one of the world’s most commonly used pain relievers and fever reducers, yet for decades, its precise biological mechanism has remained something of a mystery. Traditionally, scientists believed its analgesic effect stemmed from central nervous system activity—specifically through the action of its metabolite, AM404, on cannabinoid and TRPV1 receptors in the brain.
ASCO, Author Interviews, Cancer Research, General Medicine, Pediatrics / 01.06.2025

MedicalResearch.com Interview with: [caption id="attachment_68862" align="alignleft" width="147"]Alique Topalian, PhD, MPHResearch Scientist Family & Community Medicine | College of Medicine University of Cincinatti Dr. Topalian[/caption] Alique Topalian, PhD, MPH Research Scientist Family & Community Medicine | College of Medicine University of Cincinatti MedicalResearch.com: What is the background for this study? Response: Adolescent and young adult (AYA) cancer survivors are diagnosed between the ages of 18-39. We have seen increases in cancer diagnoses in this younger population of about 1-2% per year with an estimated total increase of 30% between 2019-2030.  Adolescent and young adult (AYA) cancer survivors experience early development of chronic medical conditions compared to healthy peers. Due to their young age at diagnosis and living decades beyond treatment, they are also at higher risk for second primary malignancies (SPM) and late effects than older adult-onset cancer survivors. Primary care providers are responsible for most long-term care of survivors and many are unfamiliar with the effects of cancer treatment in younger populations.
Alcohol, ASCO, Author Interviews, Cancer Research / 01.06.2025

MedicalResearch.com Interview with: [caption id="attachment_68875" align="alignleft" width="125"]Chinmay Jani, MDChief Fellow, Hematology & Oncology University of Miami / Jackson Health System Dr. Jani[/caption] Chinmay Jani, MD Chief Fellow, Hematology & Oncology University of Miami / Jackson Health System   [caption id="attachment_68874" align="alignleft" width="125"]Dr. Lopes Dr. Lopes[/caption] Gilberto Lopes, M.D. Professor, Chief, Division of Medical Oncology Associate Director for the Cancer Center and Medical Director for International Affairs Sylvester Comprehensive Cancer Center   MedicalResearch.com: What is the background for this study? Response: There is growing evidence linking alcohol consumption to increased cancer risk and mortality. This association was recently emphasized by the former U.S. Surgeon General, prompting renewed public health interest. In response to these concerns, under the mentorship of Dr. Lopes, we evaluated national trends in alcohol-associated cancer mortality using data from the Global Burden of Disease database.
Author Interviews, Cannabis, Heart Disease / 29.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68847" align="alignleft" width="150"]Dr. Springer Dr. Springer[/caption] Matthew L. Springer, Ph.D. Associate Professor of Medicine Division of Cardiology Cardiovascular Research Institute Broad Center of Regeneration Medicine and Stem Cell Research Center for Tobacco Control Research & Education Helen Diller Family Comprehensive Cancer Center University of California, San Francisco MedicalResearch.com: What is the background for this study? Response: It's been known for many years that chronic tobacco smokers have poor endothelial function, even if they have not smoked recently, and so do non-smokers who are frequently exposed to secondhand smoke.  Endothelial dysfunction, even in otherwise outwardly healthy people, is an indication of unhealthy arteries and increased risk of cardiovascular disease later in life.  I realized that many people who would presumably avoid secondhand smoke did not mind it if it came from cannabis, and I wondered if that could be true since both kinds of smoke included the thousands of chemicals that resulted from burning plant material. A number of years ago, we developed a way to study changes in endothelial function in rats, using a technique very similar to how we measure it in humans, and we saw that, as in humans, even brief exposures to secondhand smoke from tobacco impaired vascular function in the rats.  We subsequently showed that brief exposures to secondhand smoke from marijuana, and active smoking of marijuana, similarly impaired vascular function in the rats, even if the smoke was from marijuana lacking THC and the other cannabinoids.  That again raised the question of whether the endothelial dysfunction observed in human tobacco smokers would also occur in human marijuana smokers, and whether secondhand smoke from marijuana should be avoided like secondhand smoke from tobacco. These questions form the basis of our current study..  In our study, it is quite clear that chronic cannabis smokers had endothelial dysfunction similar to that of chronic tobacco smokers.  Whether frequent exposure to secondhand marijuana smoke similarly impairs endothelial function like secondhand tobacco smoke is still unknown, and that's one of the major questions we want to answer next.
Cost of Health Care, Diabetes, Pharmaceutical Companies / 28.05.2025

Reasons for the  Price Increase of Insulin .jpg The price of insulin keeps on skyrocketing every year. According to the American Diabetes Association, spending on insulin tripled within a decade. By 2022, the cost had hit a staggering $22.3 billion. Between 2017 and 2022, the inflation-adjusted cost of insulin increased by 24%. This is a significant problem since millions of people suffering from Type 1 and Type 2 diabetes can’t go without the drug. Over the years, people have initiated an insulin overpricing lawsuit. In 2023, Eli Lilly settled for $13.5 million and agreed to cap its price at $35 for four years. So why is insulin so expensive in the United States, and what can you do about it?
Nutrition, Weight Research / 24.05.2025

[caption id="attachment_68936" align="aligncenter" width="500"]healthy food satiety Photo by Pixabay[/caption] In today's world of fad diets and miracle weight loss solutions, many are turning to medications like Ozempic for weight loss. However, nature offers several powerful approaches that can help reduce food intake naturally—without prescriptions or side effects. Let's explore how you can harness a natural alternative to Ozempic to feel satisfied with less food while still nourishing your body properly. 80Bites: The Original "Natural Ozempic" Long before weight-loss medications hit the market, the 80Bites approach pioneered the concept of portion training as the key to sustainable weight management. This methodology focuses on a simple principle: it's not just what you eat, but how much and how often that matters. The 80Bites plan gets its name from research suggesting that the human stomach is designed to comfortably process a maximum of 80 normal-sized bites of food per day. By tracking and gradually reducing your daily bite count to around this target, you naturally train your stomach to feel satisfied with less food volume and you rebalance your hormones so that leptin and ghrelin work together. Today, because of decades of dieting, obese people are abnormally hungry because their hormones malfunction. Calorie counting can lead to binging as a result of eating foods that may not satisfy but are on the diet because they are low in calories and are unlimited in terms of quantity. The 80Bites approach focuses purely on quantity. This allows you to eat the foods you enjoy. Does anyone know what kale tastes like in someone else’s mouth?
Addiction, Alcohol / 23.05.2025

[caption id="attachment_64070" align="aligncenter" width="500"]addiction-alcohol Source[/caption]

“I’m Fine” Can Hide a Lot

You get up early. You’re productive at work. You show up for your family. You even go to the gym sometimes. From the outside, everything looks good. But at the end of the day—sometimes before it—you’re pouring a drink, or two, or more. Not because you’re out of control, but because it’s how you cope. Because it’s the only thing that turns down the noise. This is the reality for countless people living with high-functioning alcohol use. It doesn’t always look like rock bottom. It looks like “fine.” But fine isn’t the same as well. And managing isn’t the same as thriving.
Addiction, Mental Health Research / 23.05.2025

[caption id="attachment_63783" align="aligncenter" width="500"]Mental Health Counseling Pexels image[/caption]

Mental Health Deserves Just as Much Care as Physical Health

Struggling with anxiety, depression, trauma, or other mental health challenges isn’t something to ignore or “push through.” Left untreated, these conditions can impact every part of your life—from relationships and work to physical health and daily functioning. The good news? Help is out there—and healing is possible. If you’re looking into mental health treatment centers in Georgia, you’ve already taken a brave and important first step. Now it’s about finding a center that offers real support, not just quick fixes.
Addiction / 23.05.2025

[caption id="attachment_68706" align="aligncenter" width="500"]behavioral-health-addiction Photo by Alex Green[/caption]

Addiction Is More Than a Substance Problem—It’s a Behavioral Health Issue

For many individuals struggling with addiction, the substance is only part of the story. Underneath the surface, there’s often a deeper battle happening—one rooted in trauma, anxiety, depression, or emotional pain that hasn’t been addressed. That’s why the most effective recovery isn’t just about getting sober—it’s about healing the mind, body, and spirit. Modern drug rehab centers in Asheville North Carolina and beyond are embracing this truth by integrating behavioral health care into every part of the recovery process. This shift is transforming outcomes and helping people find not just sobriety, but lasting stability and personal growth.
Author Interviews, Breast Cancer, Mammograms / 22.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68644" align="alignleft" width="200"]Dr Tong Li PhD | Cancer Institute NSW Early Career FellowBreast Cancer Clinical and Population Health Stream Dr Tong Li[/caption] Dr Tong Li PhD | Cancer Institute NSW Early Career Fellow Breast Cancer Clinical and Population Health Stream The Daffodil Centre, Faculty of Medicine and Health, The University of Sydney Moore Theological College | The University of Sydney | NSW | 2042    MedicalResearch.com: What is the background for this study? Response: Having a family history of breast cancer is one of the most common risk factors for women. About 8% to 11% of women in the U.S. report having a close relative diagnosed with breast cancer. These women often have dense breasts. Dense breast tissue can make standard digital mammography (DM, also known as 2D mammography) less effective in detecting cancer. Digital breast tomosynthesis (DBT), a 3D imaging technology, has become increasingly used in breast cancer screening because it improves the visibility of lesions and reduces unnecessary callbacks. However, until now, it has been unclear whether DBT offers the same benefits in women with a family history of breast cancer, especially across different family risk levels and breast density types.
Education, Pediatrics / 22.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68655" align="alignleft" width="120"]Allison Gertel-Rosenberg, M.S., VPChief Policy and Prevention Officer Nemours Children's Health Allison Gertel-Rosenberg[/caption] Allison Gertel-Rosenberg, M.S., VP Chief Policy and Prevention Officer Nemours Children's Health MedicalResearch.com: What is the background for this study? Response: This national online survey was conducted by Nemours Children’s Health to better understand the challenges educators face in supporting early literacy development among young learners. Nemours Children’s gathered insights from more than 300 certified K-3 teachers in the U.S. The findings reveal an urgent need for stronger support for early literacy. The survey shows that K-3 teachers are acutely aware of the challenges related to child literacy and believe they need more effective resources and support to help struggling students meet grade-level literacy skills.
Addiction / 17.05.2025

[caption id="attachment_68574" align="aligncenter" width="500"]addiction-support-group-freepx Source[/caption] Choosing an addiction treatment center is one of the most important decisions a person or family can make during a time of crisis. With countless options available—each claiming to offer the best path to recovery—it's easy to feel overwhelmed. But not all treatment centers are created equal. Understanding what to look for can help ensure that you or your loved one receives the most appropriate, effective care. Whether you're exploring options across the country or considering drug treatment centers in Austin, this guide will walk you through the key factors to consider.
Author Interviews, Pain Research / 14.05.2025

MedicalResearch.com Interview with: [caption id="attachment_61470" align="alignleft" width="149"]Brian J. Piper, PhD Associate Professor of Neuroscience Geisinger Commonwealth School of Medicine Scranton PA 18411 Dr. Piper[/caption] Brian J. Piper, PhD Department of Medical Education Center for Pharmacy Innovation & Outcomes Geisinger College of Health Sciences Scranton, PA 18509   MedicalResearch.com: What is the background for this study? Dr. Piper: Tapentadol has an unusual mechanism of action. This opioid is similar to morphine in that it activates mu, the main opiate receptor which is important for pain. This drug also acts similar to an antidepressant like duloxetine (Cymbalta) with equal ability to block both the norepinephrine and the serotonin transporters (Figure 1). The combination of opioid and monoaminergic activity may influence both therapeutic and side effect profiles. [caption id="attachment_68512" align="aligncenter" width="192"]Biological mechanism of action of the atypical opioid tapentadol Figure 1. Biological mechanism of action of the atypical opioid tapentadol involves binding to the mu opiate receptor, blocking the norepinephrine transporter (NET), and blocking the serotonin transporter (SERT) [1].[/caption]Tapentadol is approved in the US for moderate to severe acute pain, moderate to severe chronic pain, and neuropathic pain associated with diabetic peripheral neuropathy. However, tapentadol is not generally considered first-line for any of these indications. Although this agent has a high potential for abuse and is classified as a Schedule II substance, a manufacturer of extended release tapentadol (Grunenthal) has conducted a misinformation campaign claiming tapentadol has a “minimum potential of abuse”, does not cause respiratory depression (a well-known opioid effect), does not cause any euphoric feelings, has no street value, and is not an opioid [2]. Prior pharmacoepidemiological studies have examined the use patterns of other prescription opioids that can be misused like oxycodone [3], fentanyl [4], meperidine [5] and methadone [6] but there is limited national information about the use of tapentadol.
Author Interviews, Ophthalmology / 13.05.2025

[caption id="attachment_68499" align="aligncenter" width="500"]ocular-injuries-eye-problems Photo by Valeria Boltneva[/caption] When you experience a new or sudden symptom, especially concerning the eyes, it can be quite worrying. The problem is that modern life is very fast-paced, and many people struggle to fit appointments into their day. However, your health is the most important thing of them all, and ignoring symptoms can lead to worsening problems down the road. If you experience any of the following eye-related symptoms, book an appointment as soon as you can.

Sudden Blurry Vision

Many people in the world experience blurry vision. In fact, sometimes, the solution is as simple as getting a pair of mens reading glasses. However, sudden blurry vision can be a sign of something more serious, including:
  • Macular Edema
  • A Detached Retina
  • Glaucoma
  • Cataracts
As such, you must book an appointment as soon as possible. You might find you just need a new pair of glasses, or you may have an eye condition that requires treatment.
Author Interviews, Gastrointestinal Disease, Hepatitis - Liver Disease / 13.05.2025

MedicalResearch.com discussion with: Dr. Bertus Eksteen PhD, MBChB, FRCP Founder of the Calgary PSC Clinic Member of the Calgary Liver Unit and the Southern Alberta Liver Transplant Clinic Aspen Woods Clinic Calgary, Canada [caption id="attachment_68489" align="aligncenter" width="500"]Dr. Bertus Eksteen Dr. Bertus Eksteen[/caption] Primary sclerosing cholangitis (PSC) is a liver disease characterized by progressive inflammation and scarring of the bile ducts. PSC still has no known cause or cure and often leads to liver failure or cancer. For patients and clinicians, the lack of answers is deeply frustrating. But that's beginning to change. Thanks to genetic research, we’re uncovering clues about PSC’s origins—and why it behaves differently from patient to patient. By learning more about the genomic underpinnings of PSC, researchers can create new treatment targets, devise risk profiles for early diagnosis, and even develop better clinical tools for detecting the disease in its earliest stages.  And that path forward doesn’t just start with new treatments — it begins in the lab.

Genetic Clues to PSC Onset

PSC isn't directly inherited, but genetics likely play a significant role in determining who develops the disease. Several immune-related gene variations, particularly those related to the human leukocyte antigen (HLA) complex, have increased the risks of developing PSC.  These variations don’t cause PSC on their own— researchers believe they interact with intestinal bacteria and other environmental factors, prompting the immune system to launch an attack on the bile ducts. Understanding these genetic foundations provides a roadmap for following this disease very early. Instead of reacting to symptoms, we can start asking why specific people are predisposed in the first place. That insight is key to prevention and long-term disease management.
Accidents & Violence, Author Interviews / 09.05.2025

MedicalResearch.com Interview with: Jingzhen Ginger Yang, PhD, MPH Principal Investigator at the Center for Injury Research and Policy Abigail Wexner Research Institute at Nationwide Children’s Hospital Professor of Pediatrics at The Ohio State University College of Medicine with a courtesy appointment in the Department of Epidemiolog in The Ohio State University College of Public HealthJingzhen Ginger Yang, PhD, MPH Principal Investigator at the Center for Injury Research and Policy Abigail Wexner Research Institute at Nationwide Children’s Hospital Professor of Pediatrics at The Ohio State University College of Medicine with a courtesy appointment in the Department of Epidemiolog in The Ohio State University College of Public Health MedicalResearch.com: What is the background for this study? Response: Motor vehicle crashes are the leading cause of death for U.S. teens. Newer vehicles and driver assistance technologies show promise in reducing crashes and injury severities. Our study found that driving vehicles 6-15 years old had a 19% greater risk of driver death in fatal crashes, and driving vehicles older than 15 years had a 31% greater risk, both compared to driving vehicles 5 years old or newer, regardless of driver age. Additionally, each driver assistance technology already present in vehicles was associated with a 6% reduction in the risk of driver death in fatal crashes.
AACR, Author Interviews, Cancer Research / 08.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68425" align="alignleft" width="150"]Andrei Bakin Dr. Andrei Bakin[/caption] Andrei Bakin, PhD, Associate Professor of Oncology, Department of Cancer Genetics & Genomics, Roswell Park Comprehensive Cancer Center – first author of “A novel combination immunotherapy for p53 mutant metastatic breast cancer leveraging vulnerabilities in the DNA damage response” and senior author of “Novel triple-drug combination strategy for p53 mutant cancers leveraging their DNA damage response liabilities” Christos Fountzilas, MD, FACP, Associate Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center - and senior author of “A novel combination immunotherapy for p53 mutant metastatic breast cancer leveraging vulnerabilities in the DNA damage response” Mohammed Alruwaili, MS, PhD, newly graduated doctoral candidate in Cancer Genetics & Genomics at Roswell Park Comprehensive Cancer Center, first author of “Novel triple-drug combination strategy for p53 mutant cancers leveraging their DNA damage response liabilities”
AACR, Author Interviews, Breast Cancer, Cancer Research / 08.05.2025

MedicalResearch.com Interview responses from: [caption id="attachment_68422" align="alignleft" width="150"]First author Gokul Das, PhD, Professor of Oncology and Co-Director of the Breast Translational Group, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center Dr. Gokul Das[/caption] First author Gokul Das, PhD, Professor of Oncology and Co-Director of the Breast Translational Group, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center Chetan Oturkar, PhD, Research Assistant Professor in the Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, first author on the study MedicalResearch.com: What is the background for this study?  Dr. Gokul Das: Triple-negative breast cancer (TNBC) is a very aggressive subtype of breast cancer for which effective targeted therapies are not available, and which rapidly becomes resistant to chemotherapy. TNBC tumors are negative for estrogen receptor α (ERα), progesterone receptor (PR), and HER-2/neu receptor. Endocrine therapy or HER2-targeted therapies are not effective against TNBC. Currently available options including immunotherapy benefit only some patients. They are cost-prohibitive and have severe adverse effects. Therefore, there is an unmet need for rationally designed therapies for TNBC. Although ERα is absent in TNBC, majority of these tumors express estrogen receptor beta (ERβ), a structurally related but functionally distinct isoform of the estrogen receptor coded by a different gene. Tumor suppressor protein p53 is mutated in the majority (80%) of TNBC. p53, when mutated, loses its tumor suppression capabilities, and instead gains oncogenic or tumor-driving functions.  One of the major oncogenic functions of mutant p53 is to bind and inactivate another tumor suppressor named p73.  The Das laboratory has been focusing on the mechanisms underlying the estrogen receptor β-p53-p73 axis for discovering rational and effective therapeutic strategies against TNBC.
Author Interviews, Cancer Research, Gastrointestinal Disease / 07.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68401" align="alignleft" width="150"]Mohamed Tausif Siddiqui, MDThe study’s lead author and a Gastroenterology fellow Cleveland Clinic. Dr. Siddiqui[/caption] Mohamed Tausif Siddiqui, MD The study’s lead author and a Gastroenterology fellow Cleveland Clinic. MedicalResearch.com: What is the background for this study? Response: Our study looked at how the stage of gastric cancer diagnosis has changed over the past two decades in the U.S., using national SEER data. Gastric cancer has long been a challenge because it’s often diagnosed late, when treatment options are limited and survival rates are poor. But with advancements in endoscopic technology—like high-definition imaging, narrow-band imaging, and endoscopic ultrasound—we wanted to see if these tools were making a difference in catching cancers earlier.
Author Interviews, Cancer Research, Colon Cancer, Gastrointestinal Disease, HPV / 07.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68399" align="alignleft" width="150"]Ashley Robinson, MD, lead authorSecond-year internal medicine resident
Advocate Lutheran General Hospital Dr. Robinson[/caption] Ashley Robinson, MD, lead author Second-year internal medicine resident Advocate Lutheran General Hospital MedicalResearch.com: What is the background for this study? Response: Briefly, anal cancer makes up around 1% of gastrointestinal cancers and more than 90% of all anal cancers are caused by chronic human papillomavirus or HPV infections. In previous research, it has been noted that women over the age of 65 have rates that were increasing more than other groups and myself along with my colleagues and the principal investigator of this project, Dr. Eli Ehrenpreis, wanted to further characterize these findings, looking into more specific details of these previously noted trends. Using data from a public database ran by the National Cancer Institute called the Surveillance, Epidemiology and End Results program, also known as SEER, and their statistical analysis software, SEER*Stat, we analyzed anal cancer incidence trends, looking at differences between sex, age, and ethnicity in order to further identify specific groups that have more rapidly increasing rates than others.
Author Interviews, Laboratories, Pets / 07.05.2025

Author: Iuliia Dakhno, PhD in Veterinary Medicine Affiliation: Independent Researcher, USA Correspondence: juliadakhno@gmail.com | +1 (347) 778-1295 Abstract: This article presents a methodologically validated ELISA approach for detecting Dirofilaria repens infection in dogs. Given the emerging risk of parasite introduction to the United States, especially through imported animals and climate-related changes in vector distribution, the proposed diagnostic tool has important applications in both veterinary and public health contexts. [caption id="attachment_68377" align="aligncenter" width="874"]Dirofilaria repens Dirofilaria repens[/caption] Introduction Dirofilaria repens is a filarial nematode responsible for subcutaneous dirofilariasis in domestic and wild canids, felids, and humans. Unlike Dirofilaria immitis, which causes cardiopulmonary disease and is endemic to North America, D. repens tends to reside in subcutaneous tissues, where it forms nodules or migratory swellings. D. immitis is widely studied and routinely screened, while D. repens remains underdiagnosed due to its subtle presentation and emerging zoonotic recognition (Genchi & Kramer, 2017; Capelli et al., 2018).
Author Interviews, Gastrointestinal Disease, Hepatitis - Liver Disease, Weight Research / 07.05.2025

[caption id="attachment_68344" align="alignleft" width="200"]MedicalResearch.com Interview with:Dr. Katilyn Gernhard Dr. Gernhard[/caption] MedicalResearch.com Interview with: Dr. Katilyn Gernhard DO Internal Medicine Resident Allegheny Health Network Pittsburgh MedicalResearch.com: What is the background for this study? Response: The background for this study is the steadily rising prevalence of obesity in the United States, which has been accompanied by an increase in related comorbid conditions, including Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Bariatric surgery and GLP-1 receptor agonists are two commonly used treatment options to address obesity and its associated complications. While both have demonstrated benefits in weight loss and metabolic improvement, there has been limited direct comparison of their effectiveness specifically in patients with MASLD. Our study aimed to address this gap by comparing clinical outcomes in patients with MASLD treated with GLP-1 receptor agonists versus those treated with bariatric surgery.
Author Interviews, Gastrointestinal Disease / 07.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68373" align="alignleft" width="160"]Dr. Simon Steenson PhDPostdoctoral Research Associate
Department of Nutritional Sciences
King’s College London Dr. Steenson[/caption] Dr. Simon Steenson PhD Postdoctoral Research Associate Department of Nutritional Sciences King’s College London MedicalResearch.com: What is the background for this study? Response: Chronic constipation is something that can be embarrassing, but it affects 1 in 10 people globally. It has a big impact on people’s quality of life and treating constipation has substantial costs for the healthcare system. Dried fruits are recommended for managing constipation, but there are very few studies that have actually tested whether following this advice is helpful. To fill this gap in our knowledge, we completed the largest clinical trial to date to see whether dried fruits and fruit juices could benefit constipation symptoms. 
Author Interviews, Colon Cancer, Gastrointestinal Disease, Race/Ethnic Diversity / 04.05.2025

MedicalResearch.com Interview with: [caption id="attachment_68341" align="alignleft" width="125"]Douglas Corley, MD, PhD  Chief Research Officer, The Permanente Medical Group Kaiser Permanente, Northern California Dr. Corley[/caption] Douglas Corley, MD, PhD Chief Research Officer, The Permanente Medical Group Kaiser Permanente, Northern California MedicalResearch.com: What is the background for this study? Response: Kaiser Permanente Northern California (KPNC) is an integrated health care system that designs and implements population-based programs that support cancer prevention and early detection. In 2006, KPNC began to implement a comprehensive colorectal cancer screening program with the goal of increasing member screening rates, preventing colorectal cancer through polyp removal, and reducing cancer mortality. The initiative identifies whether screening-eligible KPNC members are up to date with their colorectal cancer screening test by either a colonoscopy or by stool-based tests, such as a fecal immunochemical testing (FIT) kit. If they are not up to date with screening, it mails them a FIT kit for at-home testing. Members can also choose other options for colorectal cancer screening, such as a colonoscopy, through their physician.
ADHD / 03.05.2025

[caption id="attachment_68329" align="aligncenter" width="500"]adhd-cbd-adults Photo by Tara Winstead:[/caption] Cognitive behavioral therapy for ADHD offers effective strategies for managing attention and organizational challenges. This therapeutic approach helps people develop practical skills while addressing thought patterns that affect daily functioning. Understanding how CBT works specifically for ADHD can help people make informed decisions about their treatment options. The combination of behavioral changes and thought pattern awareness creates opportunities for lasting improvement in daily life.

Understanding the Basics

How CBT Works for ADHD

Cognitive-behavioral therapy for ADHD focuses on changing both thoughts and behaviors that interfere with daily life. This approach recognizes that ADHD affects more than just attention - it influences how people think about themselves and their abilities. The therapy helps develop new perspectives while building practical skills. Regular practice of these techniques leads to better management of ADHD symptoms and improved daily functioning.
Author Interviews, Cannabis, Colon Cancer, UCSD / 30.04.2025

MedicalResearch.com Interview with: [caption id="attachment_68230" align="alignleft" width="150"]Raphael E. Cuomo, PhD, MPH, CPH, FRSPHProfessor, School of Medicine University of California, San Diego Dr. Cuomo[/caption] Raphael E. Cuomo, PhD, MPH, CPH, FRSPH Professor, School of Medicine University of California, San Diego MedicalResearch.com: What is the background for this study? Response: Colon cancer remains a leading cause of cancer-related death worldwide. Recent years have seen a substantial increase in cannabis use, but limited research has explored its potential influence on cancer outcomes. We conducted a large-scale retrospective cohort study using real-world clinical data to investigate whether a diagnosis of cannabis use disorder prior to colon cancer diagnosis was associated with survival outcomes.
ENT, Hearing Loss / 29.04.2025

Editor's note:  For hearing issues, ear pain, discharge or other ear issues, please consult your health care provider for specific medical advice.  [caption id="attachment_68220" align="aligncenter" width="500"]tips-good-ear-care Photo By: Kaboompics.com[/caption] Key Takeaways:
  • Simple habits can ensure ear health.
  • Learn which environmental factors to avoid.
  • Regular cleaning methods that are safe for your ears.
 

Introduction: The Importance of Ear Care

Ears are essential for hearing, preserving balance, and enhancing quality of life. Ignoring ear care can often lead to significant health issues, including infections and hearing loss. It's easy to overlook this vital part of our body, yet taking steps to maintain ear health is pivotal. Through routine practices, individuals can prevent common ear problems and ensure their ears function optimally. Proper ear care involves clean ears and entails understanding what affects ear health, allowing us to prevent issues before they arise proactively.
AACR, Author Interviews, Cancer Research / 28.04.2025

[caption id="attachment_68201" align="alignleft" width="150"]dr_aditya_shreenivas Dr. Shreenivas[/caption] MedicalResearch.com Interview with: Aditya Shreenivas M.D.,  M.S. Assistant Professor Department of Medical Oncology & Therapeutics Research City of Hope MedicalResearch.com: What is the background for this study? Response: Nasopharyngeal carcinoma (NPC) is a highly aggressive tumor of the head and neck region with a distinct geographical distribution, with incidence rates as high as 30 per 100,000 in endemic regions like Asia and North Africa but less than 1 per 100,000 worldwide. Despite comprehensive curative intent therapy, up to 30% of patients with advanced NPC experience treatment failure, primarily due to recurrence and/or metastasis. This high mortality rate highlighted the urgent need for effective treatments. Clinical trials (JUPITER-02, CAPTAIN-1st, and RATIONALE-309) showed improved progression-free survival by adding anti-PD-1 antibodies to chemotherapy for first-line treatment of recurrent or metastatic NPC. However, these studies were conducted exclusively in Asian populations. Penpulimab is a humanized anti-PD-1 antibody that's unique because it is a  IgG1 subtype with a modified Fc segment. This structure potentially improves efficacy and safety compared to other anti-PD-1 drugs through lower immune-related adverse events.